Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Kathryn Falberg Insider Profile

18 Followers

Kathryn Falberg, Director at Arcus Biosciences, holds 176.41K shares in Arcus Biosciences (Ticker: RCUS), holds 0.00 shares in Trade Desk (Ticker: TTD), holds 250.00K shares in Nuvation Bio (Ticker: NUVB).

Kathryn Falberg's Trading History

RCUSArcus Biosciences		Jun 12, 2026DirectorUninformative Buy―$3.34M
TTDTrade Desk		Mar 25, 2026DirectorUninformative Sell42.60K$0.00
NUVBNuvation Bio		Dec 05, 2022DirectorInformative Buy483.11K$1.17M
TCDAQTricida		Jun 11, 2021―Uninformative Buy―$591.63
AIMTAimmune Therapeutics		Oct 14, 2020―Uninformative Sell270.48K$0.00
SIOXSio Gene Therapies		Apr 19, 2017―Informative Buy999.99K$0.00
MDVNMedivation		Sep 30, 2016―Uninformative Sell―$3.22M
BMRNBioMarin Pharmaceutical		Jul 19, 2016DirectorUninformative Buy―$183.68K
HALOHalozyme		May 06, 2016DirectorUninformative Buy―$43.48M
JAZZJazz Pharmaceuticals		Mar 06, 2014EVP & CFOUninformative Sell242.39K$30.64M
ORKAOruka Therapeutics		Jun 17, 2009CFO and COOInformative Sell7.88K$0.00
NVLNFNovelion Therapeutics		―――$0.00
URGNUrogen Pharma		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Kathryn Falberg insider profile FAQ

What is the percentage of profitable transactions made by Kathryn Falberg?
The percentage of profitable transactions made by Kathryn Falberg is 59%.
What is the average return per transaction made by Kathryn Falberg?
The average return per transaction made by Kathryn Falberg is 23.50%.
What stocks does Kathryn Falberg hold?
Kathryn Falberg holds: RCUS, BMRN, HALO, SIOX, AIMT, TTD, URGN, TCDAQ, NUVB, MDVN, JAZZ, ORKA, NVLNF stocks.
What was Kathryn Falberg's most profitable transaction?
Kathryn Falberg’s most profitable transaction was an Informative Buy of RCUS stock on June 11, 2019. The return on the trade was 254.00%.
What is Kathryn Falberg's role in Arcus Biosciences?
Kathryn Falberg's role in Arcus Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.